These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15817241)

  • 1. Surgical management of prostate cancer: optimizing patient selections and clinical outcome.
    Maroni PD; Crawford ED
    Surg Oncol Clin N Am; 2005 Apr; 14(2):301-19. PubMed ID: 15817241
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary appraisal of radical perineal prostatectomy.
    Janoff DM; Parra RO
    J Urol; 2005 Jun; 173(6):1863-70. PubMed ID: 15879765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
    Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
    J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized prostate cancer: quality of life meets Whitmore's legacy.
    Bermejo C; Kristal AR; Zeliadt SB; Ramsey S; Thompson IM
    J Natl Cancer Inst; 2004 Sep; 96(18):1348-9. PubMed ID: 15367562
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of pelvic lymphadenectomy in prostate cancer management.
    Sivalingam S; Oxley J; Probert JL; Stolzenburg JU; Schwaibold H
    Urology; 2007 Feb; 69(2):203-9. PubMed ID: 17320652
    [No Abstract]   [Full Text] [Related]  

  • 6. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.
    Vis AN; Schröder FH; van der Kwast TH
    Eur Urol; 2006 Aug; 50(2):258-65. PubMed ID: 16413660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    van der Poel HG
    Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes.
    Colombo R; Naspro R; Salonia A; Montorsi F; Raber M; Suardi N; Saccà A; Rigatti P
    J Urol; 2006 Dec; 176(6 Pt 1):2459-63; discussion 2463. PubMed ID: 17085129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
    Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
    Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?
    Silberstein JL; Derweesh IH; Kane CJ
    Prostate Cancer Prostatic Dis; 2009; 12(3):227-32. PubMed ID: 19546882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life after radical prostatectomy.
    Liatsikos EN; Assimakopoulos K; Stolzenburg JU
    Urol Int; 2008; 80(3):226-30. PubMed ID: 18480621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Bianco FJ
    Eur Urol; 2007 Nov; 52(5):1356-7. PubMed ID: 17719718
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Karakiewicz PI
    Eur Urol; 2007 Nov; 52(5):1355-6. PubMed ID: 17719719
    [No Abstract]   [Full Text] [Related]  

  • 18. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
    Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
    BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy for clinical T3 disease: expanding indications while optimizing cancer control and quality of life.
    Hill JR; Fine SW; Zhang J; Eastham JA
    Nat Clin Pract Urol; 2007 Aug; 4(8):451-4. PubMed ID: 17673916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic radical prostatectomy in men older than 70 years of age with localized prostate cancer: comparison of morbidity, reconvalescence, and short-term clinical outcomes between younger and older men.
    Poulakis V; Witzsch U; de Vries R; Dillenburg W; Becht E
    Eur Urol; 2007 May; 51(5):1341-8; discussion 1349. PubMed ID: 17184898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.